Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Danshensu, a novel indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis effects via inhibition of JAK2-STAT3 signaling
Gang Cao, Ruyi Zhu, Ting Jiang, et al.
Phytomedicine (2019) Vol. 63, pp. 153055-153055
Closed Access | Times Cited: 36

Showing 26-50 of 36 citing articles:

New insights into fibrotic signaling in hepatocellular carcinoma
Shan Liang, Fengling Wang, Weiju Xue, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Downregulation of miR-20b-5p Contributes to the Progression of Liver Fibrosis via the STAT3 Signaling Pathway In Vivo and In Vitro
Ling Lv, Dong Wang, Jikai Yin, et al.
Digestive Diseases and Sciences (2022) Vol. 68, Iss. 2, pp. 487-496
Closed Access | Times Cited: 5
Emerging Roles on Immunological Effect of Indoleamine 2,3-Dioxygenase in Liver Injuries
Lingyan Xu, Jiawei Ling, Chang Su, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 4
Changes in cytokines and signaling pathways in different stages of hepatic fibrosis in rats
Qiangzhong Pi, Xiaoping Hua, Liping Wang, et al.
Authorea (Authorea) (2024)
Open Access
The possible pathogenesis of liver fibrosis: therapeutic potential of natural polyphenols
Chengu Niu, Jing Zhang, Patrick Okolo
Pharmacological Reports (2024) Vol. 76, Iss. 5, pp. 944-961
Closed Access
Activation of TAF9 via Danshensu-Induced Upregulation of HDAC1 Expression Alleviates Non-alcoholic Fatty Liver Disease
Ruiwen Wang, Zhecheng Wang, Ruimin Sun, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 3
Therapeutic effect and mechanism of danshensu on coronary heart disease using liquid chromatography combined with mass spectrometry metabolomics
Peng Zhou, Baisong An, Xiaolei Zhang, et al.
Journal of Chromatography B (2022) Vol. 1208, pp. 123400-123400
Closed Access | Times Cited: 2
[Baoganning formula alleviates liver fibrosis in mice by inhibiting hepatic IDO1 expression and promoting phenotypic maturation of dendritic cells].
Chan Mo, S Xie, Lei Gao, et al.
(2021) Vol. 41, Iss. 7, pp. 1002-1011
Closed Access | Times Cited: 1
Efficient production of salvianic acid A from L-dihydroxyphenylalanine through a tri-enzyme cascade
Jiahui Yang, Wanqing Wei, Changzheng Gao, et al.
Research Square (Research Square) (2023)
Open Access
JQ-1 ameliorates schistosomiasis liver fibrosis by suppressing JAK2 and STAT3 activation
Han‐Fei Ding, Jiaming Tian, Xuhan Yang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access
Effects of danshensu on the transforming growth factor-β1/smads signaling pathway in rats with lung injury
Jing Qin, Xiaoqiang Zhang, Shengyan Wang, et al.
Materials Express (2020) Vol. 10, Iss. 11, pp. 1816-1823
Closed Access
Research progress of natural products interfering with cell signaling pathway in liver fibrosis
Lijing Qin, Lu Zhang, Zhonghua Zheng, et al.
Journal of Asian Natural Products Research (2021) Vol. 24, Iss. 1, pp. 15-23
Closed Access
Previous Page - Page 2

Scroll to top